Can Viberzi contribute to Pancreatitis?
The attorneys at TheLawFirm.com have once again learned of a prescription medication causing an increased risk of pancreatitis. We recently wrote about the warning that the popular anti-depressant Viibryd may also have a increased risk of pancreatitis and pancreatic cancer. The FDA is now warning that Viberzi should not be used in patients who do not have a gallbladder.
Viberzi is a prescription medicine used to treat irritable bowel syndrome in adults when the main symptom is diarrhea (IBS-D). IBS-D affects the large intestine and causes cramping, stomach-area or abdomen pain, bloating, gas, and diarrhea. Viberzi works by decreasing bowel contractions, which leads to less diarrhea and hopefully less pain.
Health care professionals should not prescribe Viberzi in patients who do not have a gallbladder. The FDA review found these patients have an increased risk of developing serious pancreatitis that could result in hospitalization or death. Symptoms of pancreatitis have occurred with just one or two doses of Viberzi at the recommended dosage for patients and who do not consume alcohol.
If you have IBS-D, take Viberzi and do not have a gallbladder, you should talk to your doctor immediately. Your doctor may recommend that you stop taking Viberzi. You should also get emergency medical care if you develop new or worsening stomach pain, or pain in the upper right side of your abdomen that may move to your back or shoulder. This pain may occur with nausea and vomiting. These may be symptoms of pancreatitis. It is important to get medical attention immediately. Pancreatitis, when it recurs, can lead to pancreatic cancer, an especially fatal form of cancer.
See the FDA Drug Safety Communication for more information. Call now to speak with an experienced legal professional for free.
Talk with an Attorney now!
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!